This suggests a mechanism of chemotherapy resistance in BRCA2 and BRCAX cancers, which may be abrogated in BRCA1mut tumours, most likely due to inherent inactivation of RAD21, as BRCA1wt has been shown to be required to activate RAD21 function [33]. The gene discussed is RAD21; the disease is cancer.